Evotec SE (OTCMKTS:EVTCY – Get Free Report) crossed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $4.58 and traded as low as $4.23. Evotec shares last traded at $4.30, with a volume of 40,310 shares.
Evotec Price Performance
The business has a fifty day moving average price of $4.58 and a 200 day moving average price of $4.20. The company has a market cap of $1.42 billion, a price-to-earnings ratio of 10.49 and a beta of 0.98. The company has a debt-to-equity ratio of 0.53, a quick ratio of 2.50 and a current ratio of 2.57.
Evotec Company Profile
Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.
Featured Articles
- Five stocks we like better than Evotec
- Dividend Capture Strategy: What You Need to Know
- Sizing Up a New Opportunity for NVIDIA Investors
- Where Do I Find 52-Week Highs and Lows?
- Is DeepSeek Challenging NVIDIA’s AI Dominance?
- What Are Dividend Contenders? Investing in Dividend Contenders
- The 3 Biggest M&A Stock Opportunities for 2025
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
